- A person’s height may be a risk factor for varicose veins, which can be associated with other health risks.
- Genes that predict a person’s height may be at the root of this association between height and varicose veins and may provide clues for treating the condition.
Embargoed until 4 a.m. CT / 5 a.m. ET Monday, September 24, 2018
DALLAS, September 24, 2018 — A person’s height and certain genes that predict height are associated with varicose veins and may provide clues about what causes this condition and ways to prevent and treat it, according to new research in the American Heart Association’s journal Circulation.
“We may be able to leverage what we know about the biology underlying human height and use it to uncover the root causes of varicose vein disease,” said lead author Nicholas J. Leeper, M.D., from the Divisions of Vascular Surgery and Cardiovascular Medicine at Stanford University in California. “Ultimately, this may help investigators discover a therapy that can prevent or reverse this common and sometimes debilitating disease.”
More than 30 million people in the United State are estimated to have varicose veins, which is a common condition that is increasingly being associated with serious health risks, including life-limiting ulceration and venous thromboembolism, which is when a blood clot forms within a vein. However, little is known about what causes varicose vein disease or how to treat it.
The researchers used data from a massive long-term study, the UK Biobank, to look for varicose vein risk factors among 413,519 people. In addition, the researchers screened for genetic markers among 337,536 people, 9,577 of whom had varicose vein disease. Researchers confirmed that age, gender, obesity, pregnancy and history of deep vein thrombosis are risk factors for varicose veins, and also found;
- increased height increases the risk for varicose veins;
- genes that determine height also influence the development of varicose veins; and
- there is a strong genetic correlation between deep vein thrombosis and varicose veins.
“By conducting the largest genetics study ever performed for varicose vein disease, we now have a much better understanding of the biology that is altered in people at risk for disease,” said Leeper. “Ultimately, we hope to test whether those factors can be targeted, and potentially prevent or delay the development of disease in at-risk individuals.”
Co-authors are Eri Fukaya, M.D., Ph.D.; Alyssa M. Flores, B.S.; Daniel Lindholm, M.D., Ph.D.; Stefan Gustafsson, Ph.D.; Daniela Zanetti, Ph.D.; and Erik Ingelsson, M.D., Ph.D. Author disclosures are on the manuscript.
The National Institutes of Health and the Knut and Alice Wallenberg Foundation funded the study.
- Available multimedia located on the right column of the release link: https://newsroom.heart.org/news/the-taller-you-are-the-more-likely-you-may-develop-varicose-veins?preview=42cfa7c2176f5ba21e817f3fc9fcf0f9
- After September 24, view the manuscript online and the accompanying editorial.
- Beware of risk in the veins
- What is venous thromboembolism?
- Follow AHA/ASA news on Twitter @HeartNews
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals. Foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.
For Media Inquiries and AHA/ASA Spokesperson Perspective: 214-706-1173
Carrie Thacker: 214-706-1665; email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)